That's exactly it. I tweeted everyone on the clinical trials page to get updated they did following day. So they are listening. And they need to simplify a PR for folks to understand better instead of going into so much details. Highlight key points is needed. They really do need to get more involved with investors here.
Market Data 
Markets 
AI
